Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
82 | Journal of Experimental Therapeutics and Oncology | journal | 0.107 Q4 | 40 | 0 | 17 | 0 | 2 | 16 | 0.20 | 0.00 | |
81 | National Toxicology Program technical report series | journal | 0.108 | 22 | 0 | 6 | 0 | 1 | 6 | 0.20 | 0.00 | |
80 | Annals of Cancer Research and Therapy | journal | 0.135 Q4 | 7 | 23 | 82 | 638 | 22 | 81 | 0.30 | 27.74 | |
79 | NanoWorld Journal | journal | 0.188 Q4 | 6 | 42 | 26 | 1813 | 32 | 23 | 1.59 | 43.17 | |
78 | Oncology | journal | 0.381 Q4 | 83 | 54 | 341 | 749 | 283 | 253 | 0.52 | 13.87 | |
77 | Journal of Immunotherapy and Precision Oncology | journal | 0.393 Q4 | 9 | 20 | 88 | 619 | 78 | 66 | 0.86 | 30.95 | |
76 | Critical Reviews in Oncogenesis | journal | 0.395 Q4 | 57 | 27 | 98 | 2253 | 138 | 81 | 1.00 | 83.44 | |
75 | Anti-Cancer Drugs | journal | 0.471 Q4 | 102 | 239 | 427 | 7385 | 962 | 426 | 2.25 | 30.90 | |
74 | Nuclear Medicine and Biology | journal | 0.512 Q4 | 98 | 65 | 196 | 2647 | 566 | 190 | 3.03 | 40.72 | |
73 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 0.533 Q3 | 59 | 15 | 56 | 984 | 182 | 55 | 2.74 | 65.60 | |
72 | Current Pathobiology Reports | journal | 0.560 Q3 | 33 | 3 | 38 | 342 | 120 | 38 | 3.08 | 114.00 | |
71 | Technology in Cancer Research and Treatment | journal | 0.596 Q3 | 72 | 231 | 746 | 11277 | 2136 | 736 | 2.47 | 48.82 | |
70 | Cancer Investigation | journal | 0.598 Q3 | 93 | 88 | 215 | 3686 | 440 | 202 | 2.11 | 41.89 | |
69 | Current Problems in Cancer | journal | 0.612 Q3 | 47 | 57 | 242 | 2596 | 532 | 232 | 2.34 | 45.54 | |
68 | Cancer genetics | journal | 0.614 Q3 | 52 | 77 | 223 | 2774 | 431 | 218 | 1.81 | 36.03 | |
67 | Nutrition and Cancer | journal | 0.634 Q3 | 130 | 378 | 546 | 18933 | 1940 | 540 | 3.62 | 50.09 | |
66 | Tumor Biology | journal | 0.645 Q3 | 101 | 19 | 102 | 796 | 266 | 100 | 2.35 | 41.89 | |
65 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.650 Q3 | 68 | 108 | 260 | 4014 | 897 | 255 | 3.81 | 37.17 | |
64 | Oncology Research | journal | 0.658 Q3 | 76 | 24 | 249 | 1456 | 804 | 240 | 2.19 | 60.67 | |
63 | European Journal of Cancer Prevention | journal | 0.698 Q3 | 88 | 83 | 242 | 3220 | 517 | 211 | 2.05 | 38.80 | |
62 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.705 Q3 | 112 | 16 | 91 | 1231 | 209 | 86 | 2.22 | 76.94 | |
61 | Melanoma Research | journal | 0.740 Q3 | 80 | 73 | 280 | 2106 | 727 | 262 | 2.12 | 28.85 | |
60 | Molecular Imaging and Biology | journal | 0.748 Q3 | 78 | 99 | 401 | 4160 | 1266 | 381 | 3.13 | 42.02 | |
59 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.758 Q3 | 65 | 765 | 722 | 9334 | 1519 | 690 | 2.08 | 12.20 | |
58 | Medical Oncology | journal | 0.777 Q3 | 90 | 256 | 355 | 13998 | 1098 | 333 | 3.13 | 54.68 | |
57 | Cancer Drug Resistance | journal | 0.815 Q3 | 24 | 72 | 222 | 6487 | 821 | 218 | 3.35 | 90.10 | |
56 | Genes and Cancer | journal | 0.821 Q3 | 81 | 9 | 33 | 541 | 93 | 32 | 2.05 | 60.11 | |
55 | Clinical Breast Cancer | journal | 0.862 Q2 | 80 | 202 | 444 | 8147 | 1370 | 427 | 3.10 | 40.33 | |
54 | Cancer journal (Sudbury, Mass.) | journal | 0.880 Q2 | 102 | 70 | 217 | 4548 | 487 | 198 | 1.93 | 64.97 | |
53 | Current Hematologic Malignancy Reports | journal | 0.914 Q2 | 44 | 31 | 162 | 2200 | 569 | 162 | 3.06 | 70.97 | |
52 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.916 Q2 | 90 | 81 | 402 | 2740 | 975 | 368 | 2.55 | 33.83 | |
51 | Nitric Oxide - Biology and Chemistry | journal | 0.928 Q2 | 110 | 71 | 245 | 5762 | 1112 | 242 | 4.11 | 81.15 | |
50 | Current Opinion in Oncology | journal | 0.971 Q2 | 104 | 103 | 275 | 5423 | 919 | 256 | 3.20 | 52.65 | |
49 | Cancer Biology and Therapy | journal | 0.996 Q2 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | |
48 | Molecular Carcinogenesis | journal | 1.022 Q2 | 107 | 92 | 390 | 5634 | 1687 | 389 | 4.59 | 61.24 | |
47 | Stem Cell Reviews and Reports | journal | 1.067 Q2 | 87 | 197 | 359 | 16386 | 1795 | 324 | 4.88 | 83.18 | |
46 | Cancer Prevention Research | journal | 1.125 Q2 | 112 | 101 | 351 | 3421 | 1084 | 318 | 3.02 | 33.87 | |
45 | Clinical Lung Cancer | journal | 1.137 Q2 | 74 | 164 | 518 | 4988 | 1961 | 479 | 3.44 | 30.41 | |
44 | Translational Oncology | journal | 1.150 Q2 | 72 | 301 | 702 | 15578 | 3425 | 689 | 4.86 | 51.75 | |
43 | Experimental Hematology | journal | 1.182 Q2 | 129 | 76 | 260 | 4053 | 693 | 258 | 2.66 | 53.33 | |
42 | Cytotherapy | journal | 1.186 Q2 | 105 | 134 | 319 | 6783 | 1504 | 305 | 4.08 | 50.62 | |
41 | Cancer cytopathology | journal | 1.231 Q2 | 68 | 119 | 365 | 3314 | 1040 | 239 | 2.76 | 27.85 | |
40 | Breast | journal | 1.269 Q2 | 98 | 168 | 501 | 6666 | 1967 | 463 | 3.84 | 39.68 | |
39 | Genes Chromosomes and Cancer | journal | 1.362 Q2 | 130 | 78 | 272 | 3693 | 1133 | 260 | 3.87 | 47.35 | |
38 | Seminars in Radiation Oncology | journal | 1.389 Q2 | 103 | 48 | 128 | 3416 | 616 | 119 | 3.55 | 71.17 | |
37 | Journal of Immunotherapy | journal | 1.397 Q2 | 106 | 52 | 145 | 1958 | 677 | 144 | 4.01 | 37.65 | |
36 | Epigenetics | journal | 1.408 Q2 | 111 | 159 | 285 | 10682 | 1499 | 285 | 4.26 | 67.18 | |
35 | Breast Cancer Research and Treatment | journal | 1.442 Q2 | 177 | 365 | 1398 | 13956 | 5696 | 1308 | 3.55 | 38.24 | |
34 | Neoplasia | journal | 1.451 Q2 | 144 | 77 | 283 | 4322 | 1485 | 281 | 4.58 | 56.13 | |
33 | JCO Global Oncology | journal | 1.467 Q2 | 39 | 140 | 573 | 2463 | 2093 | 521 | 3.74 | 17.59 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®